分娩期间尿液药物筛查的特征与母胎结果关系
本研究回顾性分析了2017年某机构分娩单元全部6265例分娩者的病历,其中297例被开具尿液药物筛查。结果显示原住民夏威夷人或太平洋岛民更常接受检测(P<.0001),自认白人者更常阳性(P=.03),母亲结果不能可靠预测新生儿药物检测结果。
要点
- 2017年6265例分娩中仅297例被开具尿液药物筛查。
- 原住民夏威夷人或太平洋岛民更常被检测(P<.0001),自认白人者更常阳性(P=.03)。
- 作者认为母亲尿液药物检测结果与新生儿检测结果不能相互可靠预测。
核心结论
- 原住民夏威夷人和太平洋岛民更可能接受检测,而白人更可能有阳性结果;母亲结果不能可靠预测新生儿药物检测结果,反之亦然;作者建议实施标准化、无偏倚、种族中立的尿液药物筛查指南,使用包含初筛和反射确认结果的实验室检测结果。
研究设计与样本
- 本研究为回顾性病历审查,审查2017年在本机构分娩单元分娩的全部人群,共6265例分娩,其中297例被开具尿液药物筛查;收集尿液药物筛查结果信息、母亲人口学数据、母亲阳性检测后的随访及新生儿检测结果,分析个体特征与产科结局。
主要发现
- 6265例分娩中297例被开具尿液药物筛查;被检测者最常自认原住民夏威夷人或太平洋岛民(P<.0001)。
- 开具检测最常见的指征为物质使用史和产前保健不足(P<.0001)。
- 检测阳性者更可能自认白人(P=.03)并有物质使用史(P<.0001);阳性结果中24例(24%)由医务人员开具的药物所致。
- 自认原住民夏威夷人或太平洋岛民不能预测阳性结果;被检测者中36%(108/297)初筛阳性,33%(98/295)确认试验阳性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Substance use including opioids, methamphetamines, benzodiazepines, and barbiturates during pregnancy is harmful for the pregnant person and the fetus. Routine screening using validated questionnaires is recommended, but often biologic sampling is done instead. There is often bias in urine drug screening on labor and delivery units. OBJECTIVE: This study aimed to compare characteristics of people who did and did not receive urine drug screening during labor and delivery and to examine the relationship of maternal results to neonatal results. STUDY DESIGN: This was a retrospective chart review examining all people in 2017 who delivered in the labor and delivery unit at our institution. We collected urine drug screening result information, maternal demographic data, follow-up after positive maternal tests, and neonatal test results. Individual characteristics and obstetrical outcomes were analyzed. RESULTS: Of 6265 deliveries, 297 urine drug screening tests were ordered. People who were tested identified most commonly as Native Hawaiian or Pacific Islander (P<.0001). The most common indications for ordering tests were a history of substance use and insufficient prenatal care (P<.0001). People who tested positive were more likely to self-identify as White (P=.03) and have history of substance use (P<.0001). Among the positive test results, 24 (24%) were caused by a provider-ordered medication. Self-identification as Native Hawaiian or Pacific Islander was not predictive of a positive result. Of the tested people, 36% (108/297) had a positive result on preliminary testing, and 33% (98/295) on confirmatory testing. CONCLUSION: Native Hawaiians and Pacific Islanders were more likely to undergo testing, whereas White people were more likely to have a positive result. Maternal results were not reliable for predicting neonatal drug test results and vice versa. With rising rates of substance use disorders in the pregnant and reproductive-age population, standardized unbiased race-neutral guidelines for urine drug screening should be implemented using laboratory test results that include preliminary and reflex confirmatory results.
引用
- Chin JM, Chen E, Wright T, et al. Urine drug screening on labor and delivery. Am J Obstet Gynecol MFM. 2022. PMID: 36038068. doi:10.1016/j.ajogmf.2022.100733
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。